Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn’s disease

Lynn W. Maines1, Leo R. Fitzpatrick2, Cecelia L. Green1, Yan Zhuang1, Charles D. Smith1
1Apogee Biotechnology Corporation, Hershey Center for Applied Research, Hummelstown, USA
2Department of Pharmacology, Penn State College of Medicine, Hershey, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Armstrong AM, Foulkes R et al (2001) Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis. Br J Surg 88(2):235–240

Baumruker T, Bornancin F et al (2005) The role of sphingosine and ceramide kinases in inflammatory responses. Immunol Lett 96(2):175–185

Canalis E, Pereira RC et al (2002) Effects of glucocorticoids on the skeleton. J Pediatr Endocrinol Metab 15(5):1341–1345

Chalfant CE, Spiegel S (2005) Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118(Pt 20):4605–4612

El Alwani M, Wu BX et al (2006) Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther 112(1):171–183

Fitzpatrick LR, Wang J et al (2000) In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Dig Dis Sci 45(12):2327–2336

Fitzpatrick LR, Small JS et al (2007) Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel disease. Dis Colon Rectum 50(3):337–348

French K, Zhuang Y et al. (2010) Pharmacology and Antitumor Activity of ABC294640, a selective inhibitor of sphingosine kinase-2. JPET. doi: 10.1124/JPET.109.163444 (in press)

French KJ, Schrecengost RS et al (2003a) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63(18):5962–5969

French KJ, Schrecengost RS et al (2003b) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63(18):5962–5969

French KJ, Upson JJ et al (2006) Antitumor activity of sphingosine kinase inhibitors. J Pharm Exp Ther 318(2):596–603

Itagaki K, Hauser CJ (2003) Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. J Biol Chem 278(30):27540–27547

Kee TH, Vit P et al (2005) Sphingosine kinase signalling in immune cells. Clin Exp Pharmacol Physiol 32(3):153–161

Kostin S, Pool L et al (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92(7):715–724

Leclercq TM, Pitson SM (2006) Cellular signalling by sphingosine kinase and sphingosine 1-phosphate. IUBMB Life 58(8):467–472

MacKinnon AC, Buckley A et al (2002) Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 169(11):6394–6400

Maines LW, French KJ et al (2006) Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci 47(11):5022–5031

Maines LW, Fitzpatrick LR et al (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci 53(4):997–1012

Mathias S, Dressler KA et al (1991) Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc Natl Acad Sci USA 88(22):10009–10013

McCafferty DM, Miampamba M et al (1999) Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45(6):864–873

Morris GP, Beck PL et al (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96(3):795–803

Murthy S, Flanigan A (1999) Animal models of inflammatory bowel disease. Birkhauser Verlag, Basel

Nakase H, Okazaki K et al (2001) An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. J Pharmacol Exp Ther 297(3):1122–1128

Neurath MF, Fuss I et al (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27(7):1743–1750

Niwa M, Kozawa O et al (2000) Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sci 66(3):245–256

Osawa Y, Banno Y et al (2001) TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 167(1):173–180

Prieschl EE, Csonga R et al (1999) The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 190(1):1–8

Rabano M, Pena A et al (2003) Sphingosine-1-phosphate stimulates cortisol secretion. FEBS Lett 535(1–3):101–105

Sandborn WJ, Feagan BG et al (2007) Medical management of mild to moderate Crohn’s disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther 26(7):987–1003

Smith CD, French KJ et al. (2008) Sphingosine kinase inhibitors. US, Apogee Biotechnology Corporation, US 7,338,961 B2

Stasi MA, Ruggiero V et al (2004) Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H–1, 2, 4-triazole in an experimental model of colitis in the rat. Eur J Pharmacol 494(2–3):263–272

Taha TA, Hannun YA et al (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39(2):113–131

Videla S, Vilaseca J et al (2006) Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis. J Pharmacol Exp Ther 316(2):940–945

Williams KL, Fuller CR et al (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120(4):925–937

Xia P, Gamble JR et al (1998) Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci USA 95(24):14196–14201

Xia P, Wang L et al (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274(48):34499–34505

Yamanaka M, Shegogue D et al (2004) Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. J Biol Chem 279(52):53994–54001

Yatomi Y, Ruan F et al (1995) Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86(1):193–202

Zhang M, Deng C et al (2006) Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. Int Immunopharmacol 6(8):1233–1242